The Antidiabetic Effect of MSCs Is Not Impaired by Insulin Prophylaxis and Is Not Improved by a Second Dose of Cells
Author Information
Author(s): Ezquer Fernando, Ezquer Marcelo, Simon Valeska, Conget Paulette
Primary Institution: Instituto de Ciencias, Facultad de Medicina, Clinica Alemana Universidad del Desarrollo, Santiago, Chile
Hypothesis
Does insulin prophylaxis and the administration of a second dose of MSCs affect the antidiabetic therapeutic effect of MSC transplantation?
Conclusion
The therapeutic effect of MSC transplantation in diabetic mice is not affected by insulin prophylaxis and a second dose of MSCs is unnecessary.
Supporting Evidence
- MSCs improved blood glucose levels in diabetic mice.
- Insulin prophylaxis did not affect the antidiabetic effect of MSCs.
- A second dose of MSCs did not provide additional benefits.
- MSCs from healthy donors were more effective than those from diabetic mice.
Takeaway
Scientists found that giving special cells called MSCs to diabetic mice helps them control their blood sugar, and giving them more cells later doesn't make it any better.
Methodology
Diabetes was induced in mice using streptozotocin, followed by treatment with MSCs and monitoring of blood glucose and pancreatic islet recovery.
Potential Biases
Potential bias in the selection of MSC sources and the experimental design.
Limitations
The study was conducted in a mouse model, which may not fully replicate human diabetes conditions.
Participant Demographics
C57BL/6 mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website